시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 구강 점막염 치료 시장 보고서(2025년)
Oral Mucositis Treatment Global Market Report 2025
상품코드 : 1760662
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

구강 점막염 치료 시장 규모는 향후 몇 년 동안 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안에는 개인 맞춤형 의학에 대한 관심 증가, 암 환자 수의 증가, 혁신적인 의약품 개발에 대한 투자 증가, 신흥 시장의 의료비 지출 증가, 새로운 치료법에 대한 규제 당국의 승인 증가 등이 성장을 촉진할 것으로 예상됩니다. 이 기간 동안의 주요 동향으로는 구강 점막염에 대한 생물학적 제제의 발전, 효능 개선을 위한 병용 요법의 혁신, 비침습적 치료 옵션의 개발, 점막염에 대한 면역 요법의 고급 연구, 개인 맞춤형 치료 요법의 혁신 등이 있습니다.

화학요법의 사용이 증가함에 따라 구강 점막염 치료제 시장도 성장할 것으로 예상됩니다. 화학요법은 강력한 화학 물질을 사용하여 암세포를 파괴하거나 성장을 억제하는 의학적 치료법입니다. 화학요법의 사용이 증가하는 이유는 암세포를 표적으로 하는 효과가 뛰어나 환자의 완치 가능성이 높고 생존율이 높기 때문입니다. 구강 점막염 치료는 통증을 완화하고 치유를 촉진하며 화학요법으로 인한 합병증을 예방하여 치료 중 환자의 편안함을 향상시킵니다. 예를 들어, 2022년 5월 국립 의학 도서관에 따르면, 1차 화학요법이 필요한 환자 수는 2022년 980만 명에서 2040년에는 1,500만 명으로 증가할 것으로 예상됩니다. 그 결과, 화학요법의 사용이 증가하면서 구강 점막염 치료제 시장이 확대되고 있습니다.

구강 점막염 치료 시장 선도 기업들은 빠른 통증 완화를 제공하는 고급 제품 개발에 집중하고 있으며, 이는 환자 편안함 향상, 치료 준수율 개선, 그리고 더 나은 회복 결과를 지원하기 위한 목적입니다. 빠른 통증 완화 제품은 적용 시 날카로운, 타는 듯한, 또는 자극적인 감각을 유발하지 않으면서 통증을 신속히 감소시키고 장시간 완화를 유지하는 치료법을 의미합니다. 예를 들어, 2024년 10월 미국 기반 기업인 Jaguar Health는 구강 점막염 통증 관리 및 완화를 위한 FDA 승인 처방약인 Gelclair를 출시했습니다. 이 혁신적인 치료제는 보호용 젤 작용과 진정 효과를 갖춘 적용 방식으로 암 환자의 통증을 완화하고 구강 기능을 지원합니다. Gelclair는 높은 효과를 보여주며, 빠른 통증 완화와 점막 보호를 제공하여 암 환자의 구강 점막염 치료에 이상적인 치료법으로, 치료 기간 동안 편안함을 개선하고 구강 기능을 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Oral mucositis treatment refers to therapies designed to prevent or manage inflammation and ulceration of the mucous membranes in the mouth, often caused by chemotherapy or radiation. These treatments aim to reduce discomfort, prevent infections, promote oral healing, and enhance the quality of life for cancer patients undergoing aggressive therapies.

The primary types of oral mucositis treatments include pharmaceutical drugs, laser therapy, cryotherapy, oral rinses and mouthwashes, and other treatment modalities. Pharmaceutical drugs are substances used to diagnose, treat, or prevent diseases by influencing the body's functions or processes. These can be administered through various routes, such as oral, intravenous, subcutaneous, topical, and others. They are indicated for specific causes, including chemotherapy-induced oral mucositis, radiotherapy-induced oral mucositis, and other related conditions. These medications are distributed through multiple channels, including online pharmacies, retail pharmacies, hospital pharmacies, and direct sales. The medications are used by a wide range of end-users, such as hospitals, homecare settings, ambulatory surgical centers, and long-term care facilities.

The oral mucositis treatment market research report is one of a series of new reports from The Business Research Company that provides oral mucositis treatment market statistics, including the oral mucositis treatment industry global market size, regional shares, competitors with the oral mucositis treatment market share, detailed oral mucositis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the oral mucositis treatment industry. This oral mucositis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oral mucositis treatment market size has grown rapidly in recent years. It will grow from $1.77 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth during the historic period can be attributed to factors such as the increasing prevalence of cancer therapies, a rise in chemotherapy and radiation treatments, growing awareness of oral health complications, a higher demand for targeted therapies, and greater adoption of preventive and therapeutic treatments.

The oral mucositis treatment market size is expected to see rapid growth in the next few years. It will grow to $3.20 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. In the forecast period, growth is expected to be driven by a stronger focus on personalized medicine, a rise in the number of cancer patients, growing investment in innovative drug development, increasing healthcare expenditure in emerging markets, and more regulatory approvals for novel therapies. Key trends during this period include advancements in biologics for oral mucositis, innovation in combination therapies for improved efficacy, the development of non-invasive treatment options, advanced research in immunotherapy for mucositis, and innovation in personalized treatment regimens.

The growing use of chemotherapy is expected to drive the growth of the oral mucositis treatment market. Chemotherapy is a medical treatment that uses potent chemicals to destroy or inhibit the growth of cancer cells. The increased use of chemotherapy is due to its effectiveness in targeting cancer cells, providing patients with a higher chance of remission and better survival rates. Oral mucositis treatment alleviates pain, promotes healing, and prevents complications caused by chemotherapy, improving patient comfort during treatment. For example, according to the National Library of Medicine in May 2022, the number of patients requiring first-line chemotherapy is projected to rise from 9.8 million in 2022 to 15 million by 2040. As a result, the growing use of chemotherapy is driving the expansion of the oral mucositis treatment market.

Leading companies in the oral mucositis treatment market are focusing on developing advanced products that provide quick pain relief, aiming to improve patient comfort, enhance adherence to treatment, and support better recovery outcomes. Quick pain relief products refer to treatments that swiftly reduce pain and maintain relief over time without causing sharp, burning, or irritating sensations upon application. For example, in October 2024, Jaguar Health, a US-based company, launched Gelclair, an FDA-approved prescription product for managing and relieving oral mucositis pain. This innovative treatment features a protective gel action and soothing application, helping relieve pain and support oral function in cancer patients. Gelclair is highly effective, offering rapid pain relief and mucosal protection, making it an ideal treatment for oral mucositis in cancer patients, improving comfort and supporting oral function during therapy.

In July 2022, Solasia Pharma K.K., a Japan-based pharmaceutical company, acquired Camurus AB for an undisclosed amount. This acquisition allowed Solasia Pharma to enhance its oncology and pain management portfolio by integrating Camurus AB's innovative drug delivery technologies and pipeline products. Camurus AB, a pharmaceutical company based in Sweden, offers treatments for oral mucositis.

Major players in the oral mucositis treatment market are Sanofi S.A., Amgen Inc., Colgate-Palmolive Company, Aspen Pharmacare Holdings Limited, Swedish Orphan Biovitrum AB (Sobi), Sunstar Group, Norgine B.V., Alliance Pharma plc, Camurus AB, EUSA Pharma, Galera Therapeutics Inc., Enzychem Lifesciences Corporation, CANbridge Pharmaceuticals Inc., Jaguar Health Inc., Monopar Therapeutics Inc., EpicentRx Inc., Innovation Pharmaceuticals Inc., Oragenics Inc., Soleva Pharma LLC, Soligenix Inc.

North America was the largest region in the oral mucositis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oral mucositis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oral mucositis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral mucositis treatment market consists of revenues earned by entities by providing services such as pain management, and antimicrobial treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral mucositis treatment market also includes sales of topical anesthetics, and anti-inflammatory agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Mucositis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral mucositis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for oral mucositis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral mucositis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Oral Mucositis Treatment Market Characteristics

3. Oral Mucositis Treatment Market Trends And Strategies

4. Oral Mucositis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oral Mucositis Treatment Growth Analysis And Strategic Analysis Framework

6. Oral Mucositis Treatment Market Segmentation

7. Oral Mucositis Treatment Market Regional And Country Analysis

8. Asia-Pacific Oral Mucositis Treatment Market

9. China Oral Mucositis Treatment Market

10. India Oral Mucositis Treatment Market

11. Japan Oral Mucositis Treatment Market

12. Australia Oral Mucositis Treatment Market

13. Indonesia Oral Mucositis Treatment Market

14. South Korea Oral Mucositis Treatment Market

15. Western Europe Oral Mucositis Treatment Market

16. UK Oral Mucositis Treatment Market

17. Germany Oral Mucositis Treatment Market

18. France Oral Mucositis Treatment Market

19. Italy Oral Mucositis Treatment Market

20. Spain Oral Mucositis Treatment Market

21. Eastern Europe Oral Mucositis Treatment Market

22. Russia Oral Mucositis Treatment Market

23. North America Oral Mucositis Treatment Market

24. USA Oral Mucositis Treatment Market

25. Canada Oral Mucositis Treatment Market

26. South America Oral Mucositis Treatment Market

27. Brazil Oral Mucositis Treatment Market

28. Middle East Oral Mucositis Treatment Market

29. Africa Oral Mucositis Treatment Market

30. Oral Mucositis Treatment Market Competitive Landscape And Company Profiles

31. Oral Mucositis Treatment Market Other Major And Innovative Companies

32. Global Oral Mucositis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Mucositis Treatment Market

34. Recent Developments In The Oral Mucositis Treatment Market

35. Oral Mucositis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기